Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2006-11-07
2006-11-07
Saeed, Kamal A. (Department: 1626)
Organic compounds -- part of the class 532-570 series
Organic compounds
Heterocyclic carbon compounds containing a hetero ring...
C548S539000, C548S531000, C548S570000
Reexamination Certificate
active
07132551
ABSTRACT:
One aspect of the present invention relates to heterocyclic compounds. A second aspect of the present invention relates to the use of the heterocyclic compounds as ligands for various mammalian cellular receptors, including dopamine, serotonin, or norepinephrine transporters. The compounds of the present invention will find use in the treatment of numerous ailments, conditions and diseases which afflict mammals, including but not limited to addiction, anxiety, depression, sexual dysfunction, hypertension, migraine, Alzheimer's disease, obesity, emesis, psychosis, schizophrenia, Parkinson's disease, inflammatory pain, neuropathic pain, Lesche-Nyhane disease, Wilson's disease, and Tourette's syndrome. An additional aspect of the present invention relates to the synthesis of combinatorial libraries of the heterocyclic compounds, and the screening of those libraries for biological activity, e.g., in assays based on dopamine transporters.
REFERENCES:
patent: 3806595 (1974-04-01), Jaggers et al.
patent: 3876769 (1975-04-01), Mallion et al.
patent: 3959273 (1976-05-01), Mallion et al.
patent: 4033951 (1977-07-01), Maiser
patent: 4241059 (1980-12-01), Hauck et al.
patent: 4593036 (1986-06-01), Lassen et al.
patent: 4605654 (1986-08-01), Cousse et al.
patent: 5328917 (1994-07-01), Jakobsen et al.
patent: 5521180 (1996-05-01), Fujii et al.
patent: 6110937 (2000-08-01), Loughhead et al.
patent: 6124317 (2000-09-01), Bigge et al.
patent: 6124323 (2000-09-01), Bigge et al.
patent: 6653478 (2003-11-01), Urbanski et al.
patent: 6703508 (2004-03-01), Aquila et al.
patent: 0 000 693 (1979-02-01), None
patent: 0 076 089 (1983-04-01), None
patent: 0 080 940 (1983-06-01), None
patent: 0 138 716 (1985-04-01), None
patent: 0 229 623 (1987-07-01), None
patent: 0 266 574 (1988-05-01), None
patent: 0 290 958 (1988-11-01), None
patent: 0 639 568 (1995-02-01), None
patent: 1.221.294 (1960-06-01), None
patent: 2 248 049 (1975-05-01), None
patent: 2 471 378 (1981-06-01), None
patent: 2 534 915 (1984-04-01), None
patent: 2 553 411 (1985-04-01), None
patent: 2 564 462 (1985-11-01), None
patent: 1138405 (1969-01-01), None
patent: 1184023 (1970-03-01), None
patent: 1 260 886 (1972-01-01), None
patent: 1 382 526 (1975-02-01), None
patent: 1 382 965 (1975-02-01), None
patent: 1 452 701 (1976-10-01), None
patent: 1 501 321 (1978-02-01), None
patent: 111542 (1965-06-01), None
patent: WO 91/09032 (1991-06-01), None
patent: WO 92/01672 (1992-02-01), None
patent: WO 92/02502 (1992-02-01), None
patent: WO 93/15052 (1993-08-01), None
patent: WO 94/13291 (1994-06-01), None
patent: WO 95/03302 (1995-02-01), None
patent: WO 95/25732 (1995-09-01), None
patent: WO 95/33722 (1995-12-01), None
patent: WO 95/33723 (1995-12-01), None
patent: WO 98/51668 (1998-11-01), None
patent: WO 99/65487 (1999-12-01), None
patent: WO 00/09491 (2000-02-01), None
patent: WO 0071518 (2000-11-01), None
patent: WO 01/32178 (2001-05-01), None
patent: WO 01/68604 (2001-09-01), None
patent: WO 01/92226 (2001-12-01), None
Nagahara et al., 1994, CAS: 120:323168.
Kutsuki et al., 1990, CAS: 112: 7363.
Andersson et al., 2001, CAS: 135:242140.
Brown et al., 1990, CAS:112:35578.
Engelstoft and Hansen; “Synthesis and 5HT Modulating Activity of Stereoisomers of 3-Phenoxymethyl-4-Phenylpiperidines” Acta Chemica Scandinavica 50:164-169, (1996).
O'Neill et al.; “Effect of Ca2+ and Na+ Channel Inhibitors in Vitro and In Global Cerebral Ischaemia in Vivo”, European Journal of Pharmocology 332: 121-131, (1997).
Balsamo et al., “3-[(2-Ethoxyphenoxy)methyl]piperidine Derivatives. Synthesis and Antidepressant Activity,” J. Med. Chem., 30:222-225 (1987).
Jones et al., “The Medical Benefit of 5-HT Research,” Pharmacology, Biochemistry and Behavior 71:555-568 (2002).
Aquila Brian M.
Bannister Thomas D.
Cuny Gregory D.
Hauske James R.
Holland Joanne M.
Foley & Hoag LLP
Gordon Dana M.
Sepracor Inc.
Shiao Robert
LandOfFree
Ligands for monoamine receptors and transporters, and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Ligands for monoamine receptors and transporters, and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Ligands for monoamine receptors and transporters, and... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3640138